Merck: One Of The Best - Unveiling The Trifecta Of Safety, Dividends, And Growth

Fischerrx6 Introduction As we head into the last trading days of 2023, I wanted to cover a stock I haven't discussed before on Seeking Alpha. That company is Merck & Co. (NYSE:MRK), a drug manufacturer with a market cap of more than $270 billion. The reason why I never covered MRK is because I thought it was too boring. I was wrong. Very wrong. Over the past ten years, MRK shares have returned 215%, beating both the healthcare ETF (XLV) and the S&P 500. Data by YCharts Moreover, the stock is yielding 2. ...